1. Home
  2. SHFS vs CODX Comparison

SHFS vs CODX Comparison

Compare SHFS & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHFS
  • CODX
  • Stock Information
  • Founded
  • SHFS 2015
  • CODX 2013
  • Country
  • SHFS United States
  • CODX United States
  • Employees
  • SHFS N/A
  • CODX N/A
  • Industry
  • SHFS Finance: Consumer Services
  • CODX Medical/Dental Instruments
  • Sector
  • SHFS Finance
  • CODX Health Care
  • Exchange
  • SHFS Nasdaq
  • CODX Nasdaq
  • Market Cap
  • SHFS 22.4M
  • CODX 23.6M
  • IPO Year
  • SHFS N/A
  • CODX 2017
  • Fundamental
  • Price
  • SHFS $0.42
  • CODX $0.73
  • Analyst Decision
  • SHFS
  • CODX Hold
  • Analyst Count
  • SHFS 0
  • CODX 1
  • Target Price
  • SHFS N/A
  • CODX $1.50
  • AVG Volume (30 Days)
  • SHFS 192.3K
  • CODX 187.1K
  • Earning Date
  • SHFS 11-12-2024
  • CODX 11-07-2024
  • Dividend Yield
  • SHFS N/A
  • CODX N/A
  • EPS Growth
  • SHFS N/A
  • CODX N/A
  • EPS
  • SHFS 0.10
  • CODX N/A
  • Revenue
  • SHFS $15,658,629.00
  • CODX $7,321,012.00
  • Revenue This Year
  • SHFS N/A
  • CODX N/A
  • Revenue Next Year
  • SHFS N/A
  • CODX N/A
  • P/E Ratio
  • SHFS $4.08
  • CODX N/A
  • Revenue Growth
  • SHFS 7.78
  • CODX 57.16
  • 52 Week Low
  • SHFS $0.30
  • CODX $0.70
  • 52 Week High
  • SHFS $1.55
  • CODX $2.23
  • Technical
  • Relative Strength Index (RSI)
  • SHFS 53.70
  • CODX 24.04
  • Support Level
  • SHFS $0.37
  • CODX $0.70
  • Resistance Level
  • SHFS $0.44
  • CODX $0.87
  • Average True Range (ATR)
  • SHFS 0.04
  • CODX 0.06
  • MACD
  • SHFS 0.00
  • CODX -0.00
  • Stochastic Oscillator
  • SHFS 59.85
  • CODX 12.00

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: